Angela Mauriello1, Beatrice Cavalluzzo1, Concetta Ragone1

  • 1Innovative Immunological Models Unit, Istituto Nazionale Tumori IRCCS - "Fond G. Pascale", Via Mariano Semmola, 52, Naples, Italy.

概括

这项研究确定了跨常见癌症突变的共享突变新抗原 (SNV和InDel-NeoAgs). 这些新抗原对于为广泛的患者群体开发"现成"癌症疫苗至关重要.

相关概念视频

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
321